Skip to content

Journal of Cerebral Blood Flow & Metabolism

ISSN 1559-7016, 0271-678X

7 papers in the library · 116 citations · publishing 1992-2026

Papers

Sort Most recent Most cited

Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [18F]FDG-PET study.

Journal of Cerebral Blood Flow & Metabolism June 1, 2026 Klemens Egger, Robert Bozsak, Helena Aicher et al.

Classical psychedelics such as N,N-dimethyltryptamine (DMT) modulate consciousness via serotonergic receptor agonism, and are increasingly investigated for their psychotherapeutic potential. When combined with the monoamine oxidase A (MAO-A) inhibitor harmine-mimicking the pharmacological profile of ayahuasca-oral DMT induces a psychedelic experience lasting 4-5 h. While some neuroimaging...

Concurrent assessment of neurometabolism and brain hemodynamics to characterize the functional brain response to psychotropic drugs: An S-ketamine study.

Journal of Cerebral Blood Flow & Metabolism April 1, 2026 Daphne E Boucherie, Liesbeth Reneman, Jan Booij et al.

Neuroimaging techniques offer valuable insights for understanding pharmacological treatment effects in neuropsychiatric disorders. Here, we present a novel approach that simultaneously assesses hemodynamic and neurometabolic brain responses to psychotropic drugs using interleaved pharmacological magnetic resonance imaging (phMRI) and pharmacological magnetic resonance spectroscopy (phMRS). This...

Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach.

Journal of Cerebral Blood Flow & Metabolism March 21, 2026 Claudio Agnorelli, Joseph Peill, Gabriela Sawicka et al.

We investigated ketamine's neuroplastic effects in healthy human subjects using integrated Positron Emission Tomography (PET)/Magnetic Resonance Imaging (MRI) measures before and 1-8 days after a single psychedelic dose of ketamine (1 mg/kg, intravenous). Eleven male participants underwent two PET/MRI scans with [11C]-UCBJ (synaptic density/plasticity), 1H-MRS (glutamate and GABA) and...

Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans.

Journal of Cerebral Blood Flow & Metabolism February 26, 2025 Kristian Larsen, Ulrich Lindberg, Brice Ozenne et al. 9 citations

Psilocin, the active metabolite of psilocybin, is a psychedelic and agonist at the serotonin 2A receptor (5-HT2AR) that has shown positive therapeutic effects for brain disorders such as depression. To elucidate the brain effects of psilocybin, we directly compared the acute effects of 5-HT2AR agonist (psilocybin) and antagonist (ketanserin) on cerebral blood flow (CBF) using pseudo-continuous...

DOI: 10.1177/0271678x251323364 (opens in new tab) Full text (opens in new tab) Psilocybin Psychedelics hallucinogens Entheogens Psychedelic drugs +9

Neurochemical characterization of 5-HT 2A R partial agonists with simultaneous PET-MRI

Journal of Cerebral Blood Flow & Metabolism November 29, 2024 Frederick A. Bagdasarian, Kristian Larsen, Deng Hong et al. 1 citation

Understanding neuromodulatory effects of serotonin 2A receptor (5-HT 2A R) agonists with diverse pharmacological profiles is relevant to advancing psychedelic-related drug applications. We performed simultaneous positron emission tomography (PET) and pharmacological magnetic resonance imaging (phMRI) in anesthetized nonhuman primates (NHP; N = 3) to examine partial agonists with varying 5-HT 2A...

DOI: 10.1177/0271678x241302937 (opens in new tab) Full text (opens in new tab) Serotonin Neurochemical Characterization materials science 5-HT Receptor +2

Serotonin 2A Receptor Agonist Binding in the Human Brain with [11C]Cimbi-36

Journal of Cerebral Blood Flow & Metabolism April 30, 2014 Anders Ettrup, Sofi Da Cunha‐bang, Brenda Mcmahon et al. 106 citations

[ 11 C]Cimbi-36 was recently developed as a selective serotonin 2A (5-HT 2A ) receptor agonist radioligand for positron emission tomography (PET) brain imaging. Such an agonist PET radioligand may provide a novel, and more functional, measure of the serotonergic system and agonist binding is more likely than antagonist binding to reflect 5-HT levels in vivo. Here, we show data from a...

DOI: 10.1038/jcbfm.2014.68 (opens in new tab) Serotonin agonist Human brain 5-HT Receptor Endocrinology +1

Regional cerebral blood flow after marijuana smoking.

Journal of Cerebral Blood Flow & Metabolism September 1992 R J Mathew, W H Wilson, D F Humphreys et al.

Regional CBF was measured with the 133Xe inhalation technique before and thrice after smoking marijuana of two strengths and placebo in 20 physically and mentally healthy male volunteers with a previous history of exposure to marijuana. They were drug-free at the time of the study. Blood pressure, pulse rate, end-tidal carbon dioxide, end-tidal carbon monoxide, and forehead skin perfusion were...